Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform
Purple Biotech announced the establishment of a Scientific Advisory Board (SAB) comprising leading experts in T-cell and NK cell engager therapies and tumor immunology. The SAB will advise the company on the development of its CAPTN-3 tri-specific antibody platform aimed at maximizing anti-cancer efficacy while minimizing toxicity by activating imm…